Flomoxef
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(6R,7R)-7-[[2-(Difluoromethylsulfanyl)acetyl]amino]-3-[[1-(2-hydroxyethyl)tetrazol-5-yl]sulfanylmethyl]-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number |
99665-00-6 |
| ATC code | J01DC14 |
| PubChem | CID 65864 |
| ChemSpider | 59274 |
| UNII |
V9E5U5XF42 |
| KEGG |
D07963 |
| ChEMBL |
CHEMBL15413 |
| Chemical data | |
| Formula | C15H18F2N6O7S2 |
| Molar mass | 496.46 g/mol |
| |
| |
| | |
Flomoxef (INN) is an oxacephem antibiotic.
It has been classified as second-generation[1] and fourth-generation.[2]
References
- ↑ Masuda Z, Kurosaki Y, Ishino K, Yamauchi K, Sano S (April 2008). "Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration". Gen Thorac Cardiovasc Surg 56 (4): 163–9. doi:10.1007/s11748-007-0208-5. PMID 18401677.
- ↑ Ito M, Ishigami T (1991). "The meaning of the development of flomoxef and clinical experience in Japan". Infection. 19 Suppl 5: S253–7. doi:10.1007/bf01645536. PMID 1783441.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Friday, February 26, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
